Establishment and characterization of a human B cell line from the lung tissue of a patient with scleroderma; extraordinary high level of IL-6 secretion by stimulated fibroblasts

Cytokine

Volumn 13, Issue 4, 2001, Pages 220-226

  Kondo, Kazuo ^a   Okada, Tadashi ^a   Matsui, Takuya ^a   Kato, Shinji ^a   Date, Kazuhiko ^a   Yoshihara, Masashi ^a   Nagata, Yoshihisa ^a   Takagi, Hidekazu ^a   Yoneda, Masahiko ^a   Sugie, Isamu ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoimmunity; B lymphocytes; Fibrosis; Human lung; Scleroderma

Indexed keywords

COLLAGEN; CYTOKINE; GLYCOSAMINOGLYCAN; INTERLEUKIN 6; MESSENGER RNA;

ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCLERODERMA; SYSTEMIC SCLEROSIS;

SCLERODERMA;

EID: 0035925040     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0822     Document Type: Article

References (28)

1. Classification of systemic sclerosis (scleroderma)
2. Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis
3. Subpopulations of human T lymphocytes: IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis
4. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis
5. Antinuclear and precipitating autoantibodies in progressive systemic sclerosis
6. Rheumatoid factor
7. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma)
8. Abnormalities of immunoregulation in progressive systemic sclerosis: Evidence for excess helper-cell function and altered B-cell function
9. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma)
10. Interleukin-6: An overview
11. Interleukin-6 and its relation to inflammation and disease
12. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis
13. Synovium as a source of interleukin 6 in vivo. Contribution to local and systemic manifestations of arthritis
14. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon-γ levels in sera from patients with scleroderma
15. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders
16. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis
17. Interleukin 6 is required for the development of collagen-induced arthritis
18. Interleukin-6 and its receptor: A paradigm for cytokines
19. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis
20. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
21. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6
22. Interleukin 1 and tumor necrosis factor-α synergistically increase the production of Interleukin 6 in human synovial fibroblast
23. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome
24. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis
25. - cell population
26. Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells
27. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species
28. DNA sequence and expression of the B95-8 Epstein-Barr virus genome